Dr Reddys
Menu
Global Site
  • Australia
  • Canada
  • China
  • France
  • Germany
  • India
  • Netherlands
  • New Zealand
  • Romania
  • Russia
  • South Africa
  • Spain
  • Ukraine
  • United Kingdom
  • United States
  • Brazil
  • Our Story
    • Brand
    • Heritage
      • Our Founder
      • Milestones
      • An Unfinished Agenda
    • Leadership
      • Board Of Directors
      • Management Council
    • Featured Stories
  • Our Products
    • Business Porfolio
      • Generics
      • Over-the-counter
      • APIs (Active Pharmaceutical Ingredients)
      • Biologics
      • Differentiated Formulations
      • Custom Pharma Services (CPS)
    • Quality
    • Therapeutic Focus
  • Our Science
    • Research Philosophy
    • Development Streams
      • Generics
      • APIs (Active Pharmaceutical Ingredients)
      • Biologics
      • Proprietary Products
    • Capabilities
  • Our People
    • Life at Dr.Reddy's
    • Humans of Dr. Reddy’s
  • Our Citizenship
    • Patients
    • Healthcare Professionals
    • Community
      • Our Approach
      • Education
      • Livelihoods
      • Healthcare
      • Change Makers
    • Planet
      • Commitment to the Planet
      • Initiatives
      • Carbon Footprint
    • Affiliates
      • Dr Reddy’s Foundations
      • Partners
    • Sustainability
  • Investors
    • Reports and Filings
      • Annual Reports
      • Quarterly Reports
      • SEC Filings
      • 34th Annual General Meeting
      • AGM Voting Results
      • MoA and AoA
    • Presentations
      • Presentations
      • Earnings Call
    • Shares
      • Share Price
      • Stock Updates
      • Equity & Dividend History
      • Unpaid & Unclaimed Dividend
      • Analyst Coverage
      • Shareholding Pattern
      • Share Transfer Information
      • Buyback
      • Details of Shares for transfer to IEPF August 17
      • Notice pursuant to IEPF Rules, Aug 17
      • Details of Shares for transfer to IEPF May 2018
      • Notice pursuant to IEPF Rules, May 2018
    • Governance
      • Internal Control Systems
      • Committees of the Board
      • Code of Business Conduct and Ethics (COBE)
      • Ombudsperson Policy
      • Supplier Code of Conduct
      • Compliance with NYSE
      • Information to Stakeholders
      • Corporate Governance Reports
      • Policies and Documents
      • Data Privacy Notice
    • Investor Services
      • Statutory Communication
      • Shareholder’s Contacts
      • Shareholder Information
      • Investor Meeting Details
      • Other Stock Exchange Intimations
  • Media
    • Press Releases
    • Media Kit
    • Dr. Reddy's in the news
  • Partners
    • Prospective Partners
    • Post an Enquiry
    • Login for Current Partners
  • Canada
    • Dr. Reddy's in Canada
    • Our Products
    • Medical Information
    • Patient Care Program
    • Customer Service
    • Contact Us
  • Australia
    • Dr. Reddy's in Australia
    • Our Products
    • Our Programmes
    • Contact Us
  • Germany
    • Dr. Reddy's in Germany
    • Our Products
    • CONTACT Us
  • India
    • Dr.Reddy’s in India
    • Portfolio
      • Top Brands
      • Biosimilars
      • Differentiated Products
      • OTC List
      • Therapy Areas
    • Programs
      • For Doctors
      • For Patients
      • DRFHE
    • People
      • Working with Dr.Reddy's
      • Careers
    • Medical Information
    • Contact Us
  • New Zealand
    • Dr. Reddy's in New Zealand
    • Contact Us
  • China
    • Contact Us
    • Our Products
    • Dr. Reddy's in China
  • Netherlands
    • Dr. Reddy’s Research and Development
    • Join Us
    • Contact Us
  • Contact Us
    • Global Locations
    • Key Contacts
    • Medical Information

Investors

  • Reports and Filings
  • Presentations
  • Shares
  • Governance
  • Investor Services

Investor Services

  • Statutory Communication
  • Shareholder’s Contacts
  • Shareholder Information
  • Investor Meeting Details
  • Shareholder’s Services
  • Other Stock Exchange Intimations

Statutory Communication

Recent Yrs.
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005
  • 2004
Prev Yrs.

Earnings Call Audio Q3FY19 | Q3 FY19: Financial Performance Press Release

Our Story

  • Our Brand
  • Our Heritage
  • Leadership
  • Featured Stories

Our Products

  • Business Focus
  • Quality
  • Therapeutic Focus

Our Science

  • Research Philosophy
  • Development Streams
  • Capabilities

Our People

  • Life at Dr.Reddy's
  • Humans of Dr. Reddy’s

Our Citizenship

  • Patients
  • Healthcare Professionals
  • Community
  • Planet
  • Affiliates
  • Sustainability

Investors

Media

Partners

Contact Us

 

© 2018 Dr. Reddy’s Laboratories Ltd. All rights reserved.

 

Please read the legal notice for further details. Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Dr. Reddys Laboratories its subsidiaries or affiliates.

 

CPSIA Declaration | California Compliance | Privacy Notice | Terms Of Use | Accessibility | Cookie Policy

 

DR Popup logo

Cookie

This website uses cookies to help us give you the best experience when you visit. By using this website you consent to our use of cookies. For more information please review our cookie policy. Cookie Policy.

Accept

You are about to leave Dr.Reddy’s and affiliates website. Dr. Reddy's assumes no responsibility for the information presented on the external website or any further links from such sites. These links are presented to you only as a convenience, and the inclusion of any link does not imply endorsement by Dr. Reddy's.

If you wish to continue to this external website, click Proceed.

ProceedBack